<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />

<meta name="viewport" content="width=device-width, initial-scale=1">



<title>Trial simulation</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
div.sourceCode { overflow-x: auto; }
table.sourceCode, tr.sourceCode, td.lineNumbers, td.sourceCode {
  margin: 0; padding: 0; vertical-align: baseline; border: none; }
table.sourceCode { width: 100%; line-height: 100%; }
td.lineNumbers { text-align: right; padding-right: 4px; padding-left: 4px; color: #aaaaaa; border-right: 1px solid #aaaaaa; }
td.sourceCode { padding-left: 5px; }
code > span.kw { color: #007020; font-weight: bold; } /* Keyword */
code > span.dt { color: #902000; } /* DataType */
code > span.dv { color: #40a070; } /* DecVal */
code > span.bn { color: #40a070; } /* BaseN */
code > span.fl { color: #40a070; } /* Float */
code > span.ch { color: #4070a0; } /* Char */
code > span.st { color: #4070a0; } /* String */
code > span.co { color: #60a0b0; font-style: italic; } /* Comment */
code > span.ot { color: #007020; } /* Other */
code > span.al { color: #ff0000; font-weight: bold; } /* Alert */
code > span.fu { color: #06287e; } /* Function */
code > span.er { color: #ff0000; font-weight: bold; } /* Error */
code > span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */
code > span.cn { color: #880000; } /* Constant */
code > span.sc { color: #4070a0; } /* SpecialChar */
code > span.vs { color: #4070a0; } /* VerbatimString */
code > span.ss { color: #bb6688; } /* SpecialString */
code > span.im { } /* Import */
code > span.va { color: #19177c; } /* Variable */
code > span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code > span.op { color: #666666; } /* Operator */
code > span.bu { } /* BuiltIn */
code > span.ex { } /* Extension */
code > span.pp { color: #bc7a00; } /* Preprocessor */
code > span.at { color: #7d9029; } /* Attribute */
code > span.do { color: #ba2121; font-style: italic; } /* Documentation */
code > span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code > span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code > span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' || rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<link href="data:text/css;charset=utf-8,body%20%7B%0Abackground%2Dcolor%3A%20%23fff%3B%0Amargin%3A%201em%20auto%3B%0Amax%2Dwidth%3A%20700px%3B%0Aoverflow%3A%20visible%3B%0Apadding%2Dleft%3A%202em%3B%0Apadding%2Dright%3A%202em%3B%0Afont%2Dfamily%3A%20%22Open%20Sans%22%2C%20%22Helvetica%20Neue%22%2C%20Helvetica%2C%20Arial%2C%20sans%2Dserif%3B%0Afont%2Dsize%3A%2014px%3B%0Aline%2Dheight%3A%201%2E35%3B%0A%7D%0A%23header%20%7B%0Atext%2Dalign%3A%20center%3B%0A%7D%0A%23TOC%20%7B%0Aclear%3A%20both%3B%0Amargin%3A%200%200%2010px%2010px%3B%0Apadding%3A%204px%3B%0Awidth%3A%20400px%3B%0Aborder%3A%201px%20solid%20%23CCCCCC%3B%0Aborder%2Dradius%3A%205px%3B%0Abackground%2Dcolor%3A%20%23f6f6f6%3B%0Afont%2Dsize%3A%2013px%3B%0Aline%2Dheight%3A%201%2E3%3B%0A%7D%0A%23TOC%20%2Etoctitle%20%7B%0Afont%2Dweight%3A%20bold%3B%0Afont%2Dsize%3A%2015px%3B%0Amargin%2Dleft%3A%205px%3B%0A%7D%0A%23TOC%20ul%20%7B%0Apadding%2Dleft%3A%2040px%3B%0Amargin%2Dleft%3A%20%2D1%2E5em%3B%0Amargin%2Dtop%3A%205px%3B%0Amargin%2Dbottom%3A%205px%3B%0A%7D%0A%23TOC%20ul%20ul%20%7B%0Amargin%2Dleft%3A%20%2D2em%3B%0A%7D%0A%23TOC%20li%20%7B%0Aline%2Dheight%3A%2016px%3B%0A%7D%0Atable%20%7B%0Amargin%3A%201em%20auto%3B%0Aborder%2Dwidth%3A%201px%3B%0Aborder%2Dcolor%3A%20%23DDDDDD%3B%0Aborder%2Dstyle%3A%20outset%3B%0Aborder%2Dcollapse%3A%20collapse%3B%0A%7D%0Atable%20th%20%7B%0Aborder%2Dwidth%3A%202px%3B%0Apadding%3A%205px%3B%0Aborder%2Dstyle%3A%20inset%3B%0A%7D%0Atable%20td%20%7B%0Aborder%2Dwidth%3A%201px%3B%0Aborder%2Dstyle%3A%20inset%3B%0Aline%2Dheight%3A%2018px%3B%0Apadding%3A%205px%205px%3B%0A%7D%0Atable%2C%20table%20th%2C%20table%20td%20%7B%0Aborder%2Dleft%2Dstyle%3A%20none%3B%0Aborder%2Dright%2Dstyle%3A%20none%3B%0A%7D%0Atable%20thead%2C%20table%20tr%2Eeven%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0A%7D%0Ap%20%7B%0Amargin%3A%200%2E5em%200%3B%0A%7D%0Ablockquote%20%7B%0Abackground%2Dcolor%3A%20%23f6f6f6%3B%0Apadding%3A%200%2E25em%200%2E75em%3B%0A%7D%0Ahr%20%7B%0Aborder%2Dstyle%3A%20solid%3B%0Aborder%3A%20none%3B%0Aborder%2Dtop%3A%201px%20solid%20%23777%3B%0Amargin%3A%2028px%200%3B%0A%7D%0Adl%20%7B%0Amargin%2Dleft%3A%200%3B%0A%7D%0Adl%20dd%20%7B%0Amargin%2Dbottom%3A%2013px%3B%0Amargin%2Dleft%3A%2013px%3B%0A%7D%0Adl%20dt%20%7B%0Afont%2Dweight%3A%20bold%3B%0A%7D%0Aul%20%7B%0Amargin%2Dtop%3A%200%3B%0A%7D%0Aul%20li%20%7B%0Alist%2Dstyle%3A%20circle%20outside%3B%0A%7D%0Aul%20ul%20%7B%0Amargin%2Dbottom%3A%200%3B%0A%7D%0Apre%2C%20code%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0Aborder%2Dradius%3A%203px%3B%0Acolor%3A%20%23333%3B%0Awhite%2Dspace%3A%20pre%2Dwrap%3B%20%0A%7D%0Apre%20%7B%0Aborder%2Dradius%3A%203px%3B%0Amargin%3A%205px%200px%2010px%200px%3B%0Apadding%3A%2010px%3B%0A%7D%0Apre%3Anot%28%5Bclass%5D%29%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0A%7D%0Acode%20%7B%0Afont%2Dfamily%3A%20Consolas%2C%20Monaco%2C%20%27Courier%20New%27%2C%20monospace%3B%0Afont%2Dsize%3A%2085%25%3B%0A%7D%0Ap%20%3E%20code%2C%20li%20%3E%20code%20%7B%0Apadding%3A%202px%200px%3B%0A%7D%0Adiv%2Efigure%20%7B%0Atext%2Dalign%3A%20center%3B%0A%7D%0Aimg%20%7B%0Abackground%2Dcolor%3A%20%23FFFFFF%3B%0Apadding%3A%202px%3B%0Aborder%3A%201px%20solid%20%23DDDDDD%3B%0Aborder%2Dradius%3A%203px%3B%0Aborder%3A%201px%20solid%20%23CCCCCC%3B%0Amargin%3A%200%205px%3B%0A%7D%0Ah1%20%7B%0Amargin%2Dtop%3A%200%3B%0Afont%2Dsize%3A%2035px%3B%0Aline%2Dheight%3A%2040px%3B%0A%7D%0Ah2%20%7B%0Aborder%2Dbottom%3A%204px%20solid%20%23f7f7f7%3B%0Apadding%2Dtop%3A%2010px%3B%0Apadding%2Dbottom%3A%202px%3B%0Afont%2Dsize%3A%20145%25%3B%0A%7D%0Ah3%20%7B%0Aborder%2Dbottom%3A%202px%20solid%20%23f7f7f7%3B%0Apadding%2Dtop%3A%2010px%3B%0Afont%2Dsize%3A%20120%25%3B%0A%7D%0Ah4%20%7B%0Aborder%2Dbottom%3A%201px%20solid%20%23f7f7f7%3B%0Amargin%2Dleft%3A%208px%3B%0Afont%2Dsize%3A%20105%25%3B%0A%7D%0Ah5%2C%20h6%20%7B%0Aborder%2Dbottom%3A%201px%20solid%20%23ccc%3B%0Afont%2Dsize%3A%20105%25%3B%0A%7D%0Aa%20%7B%0Acolor%3A%20%230033dd%3B%0Atext%2Ddecoration%3A%20none%3B%0A%7D%0Aa%3Ahover%20%7B%0Acolor%3A%20%236666ff%3B%20%7D%0Aa%3Avisited%20%7B%0Acolor%3A%20%23800080%3B%20%7D%0Aa%3Avisited%3Ahover%20%7B%0Acolor%3A%20%23BB00BB%3B%20%7D%0Aa%5Bhref%5E%3D%22http%3A%22%5D%20%7B%0Atext%2Ddecoration%3A%20underline%3B%20%7D%0Aa%5Bhref%5E%3D%22https%3A%22%5D%20%7B%0Atext%2Ddecoration%3A%20underline%3B%20%7D%0A%0Acode%20%3E%20span%2Ekw%20%7B%20color%3A%20%23555%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Edt%20%7B%20color%3A%20%23902000%3B%20%7D%20%0Acode%20%3E%20span%2Edv%20%7B%20color%3A%20%2340a070%3B%20%7D%20%0Acode%20%3E%20span%2Ebn%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Efl%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Ech%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Est%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Eco%20%7B%20color%3A%20%23888888%3B%20font%2Dstyle%3A%20italic%3B%20%7D%20%0Acode%20%3E%20span%2Eot%20%7B%20color%3A%20%23007020%3B%20%7D%20%0Acode%20%3E%20span%2Eal%20%7B%20color%3A%20%23ff0000%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Efu%20%7B%20color%3A%20%23900%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%20code%20%3E%20span%2Eer%20%7B%20color%3A%20%23a61717%3B%20background%2Dcolor%3A%20%23e3d2d2%3B%20%7D%20%0A" rel="stylesheet" type="text/css" />




</head>

<body>




<h1 class="title toc-ignore">Trial simulation</h1>



<div id="overview" class="section level2">
<h2>Overview</h2>
<p>Here we provide code to simulate a single trial. See the README file and the full <a href="https://www.tandfonline.com/doi/abs/10.1080/19466315.2018.1462727">publication</a> for greater overview of the design framework.</p>
<p>The examples we will be working with are the following: suppose we have a study with 5 dose levels to test, each of which has an associated “true” toxicity level and (mean) efficacy. Additionally, we specify an acceptable and unacceptable proportion of dose-limiting toxicities (DLTs). N patients are to be assigned to each dose level. We work with a continuous efficacy outcome and binary toxicity measure. In scenario 1, we will work with a monoton dose-response relationship; in scenario 2, we will work with a non-monotone dose-response relationship.</p>
</div>
<div id="scenario-1-monotone-dose-response" class="section level2">
<h2>Scenario 1: Monotone dose-response</h2>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">library</span>(iAdapt)</code></pre></div>
<pre><code>## Loading required package: shiny</code></pre>
<pre><code>## Loading required package: shinydashboard</code></pre>
<pre><code>## 
## Attaching package: 'shinydashboard'</code></pre>
<pre><code>## The following object is masked from 'package:graphics':
## 
##     box</code></pre>
<pre><code>## 
## Attaching package: 'iAdapt'</code></pre>
<pre><code>## The following object is masked from 'package:shiny':
## 
##     runExample</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># Number of pre-specified dose levels</span>
dose &lt;-<span class="st"> </span><span class="dv">5</span> 

<span class="co"># Vector of true toxicities associated with each dose</span>
dose.tox &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="fl">0.05</span>, <span class="fl">0.10</span>, <span class="fl">0.15</span>, <span class="fl">0.20</span>, <span class="fl">0.30</span>)       

<span class="co"># Acceptable (p_yes) and unacceptable (p_no) DLT rates used for establishing safety</span>
p_no &lt;-<span class="st"> </span><span class="fl">0.25</span>                                     
p_yes &lt;-<span class="st"> </span><span class="fl">0.15</span>    

<span class="co"># Likelihood-ratio (LR) threshold</span>
K &lt;-<span class="st"> </span><span class="dv">2</span>                                          

<span class="co"># Cohort size used in stage 1</span>
coh.size &lt;-<span class="st"> </span><span class="dv">3</span> 

<span class="co"># Vector of true mean efficacies per dose (here mean percent persistence per dose)</span>
m &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">5</span>, <span class="dv">15</span>, <span class="dv">40</span>, <span class="dv">65</span>, <span class="dv">80</span>)   <span class="co"># MUST BE THE SAME LENGTH AS dose.tox                  </span>

<span class="co"># Efficacy(equal) variance per dose</span>
v &lt;-<span class="st"> </span><span class="kw">rep</span>(<span class="fl">0.01</span>, <span class="dv">5</span>) 

<span class="co"># Total sample size (stages 1&amp;2)                            </span>
N &lt;-<span class="st"> </span><span class="dv">25</span>                                        

<span class="co"># Stopping rule: if dose 1 is the only safe dose, allocate up to 9 pts.</span>
stop.rule &lt;-<span class="st"> </span><span class="dv">9</span>   </code></pre></div>
<p>Note that, as we’ve specified them, we have monotone dose-toxicity and dose-response curves, as shown below. If we have a cutoff dose-limiting toxicity (DLT) rate of 0.25, (horizontal dotted line, figure a), then our target dose is dose 4 (green point). Using a likelihood framework, our design should, on average, choose this dose-level with high accuracy.</p>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<div id="stage-1" class="section level3">
<h3>Stage 1</h3>
<p>Stage 1 establishes the safety profiles of the predefined doses.</p>
<p>Function to generate and tabulate toxicities per dose level:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">set.seed</span>(<span class="dv">2</span>)
<span class="kw">tox.profile</span>(<span class="dt">dose =</span> dose, <span class="dt">dose.tox =</span> dose.tox, <span class="dt">p1 =</span> p_no, <span class="dt">p2 =</span> p_yes, <span class="dt">K =</span> K, <span class="dt">coh.size =</span> coh.size)</code></pre></div>
<pre><code>##      [,1] [,2] [,3] [,4]
## [1,]    1    0    1 1.46
## [2,]    2    0    2 1.46
## [3,]    3    0    3 1.46
## [4,]    4    0    4 1.46
## [5,]    5    2    5 0.41</code></pre>
<p>The first and third columns give the dose assignment for all specified doses (in this case, 5). The second column gives the number of DLTs observed at that dose. The fourth column gives the likelihood ratio of acceptable toxicity (in this case, DLT rate &lt;0.25).</p>
<p>Now let’s see which doses the design selects as being acceptably toxic.</p>
<p>Function to select only the acceptable toxic doses:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">set.seed</span>(<span class="dv">2</span>)
<span class="kw">safe.dose</span>(<span class="dt">dose =</span> dose, <span class="dt">dose.tox =</span> dose.tox, <span class="dt">p1 =</span> p_no, <span class="dt">p2 =</span> p_yes, <span class="dt">K =</span> K, <span class="dt">coh.size =</span> coh.size) </code></pre></div>
<pre><code>## $alloc.safe
##      [,1] [,2]
## [1,]    1    0
## [2,]    2    0
## [3,]    3    0
## [4,]    4    0
## 
## $alloc.total
##  [1] 1 1 1 2 2 2 3 3 3 4 4 4 5 5 5
## 
## $n1
## [1] 15</code></pre>
<p>We can see that the design selects only doses 1 through 4; $alloc.safe gives the dose assignment (first column) and number of DLTs (second column). $alloc.total gives the dose assignment for all enrolled patients ($n1 gives total sample size, in this case 15 subjects), where we see that 3 patients were assigned to each dose as specified by <code>coh.size</code>.</p>
<p>As the design allows, we can also begin collecting safety information for each dose.</p>
<p>Function to generate efficacy outcomes (here percent persistence) for each dose:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">set.seed</span>(<span class="dv">2</span>)
<span class="kw">eff.stg1</span>(<span class="dt">dose =</span> dose, <span class="dt">dose.tox =</span> dose.tox, <span class="dt">p1 =</span> p_no, <span class="dt">p2 =</span> p_yes, <span class="dt">K =</span> K, <span class="dt">coh.size =</span> coh.size, m, v, <span class="dt">nbb =</span> <span class="dv">100</span>)</code></pre></div>
<pre><code>## $Y.safe
##  [1]  0  7  4  2 37  6 40 44 32 64 79 72
## 
## $d.safe
##  [1] 1 1 1 2 2 2 3 3 3 4 4 4
## 
## $tox.safe
## [1] 0 0 0 0
## 
## $n1
## [1] 15
## 
## $Y.alloc
##  [1]  0  7  4  2 37  6 40 44 32 64 79 72 87 76 98
## 
## $d.alloc
##  [1] 1 1 1 2 2 2 3 3 3 4 4 4 5 5 5</code></pre>
<p>$Y.safe and $d.safe gives the efficacies and dose allocation for all subject enrolled on acceptably toxic doses; $tox.safe gives the number of DLTs for each dose level; $Y.alloc and $d.alloc gives the efficacies and dose allocation for all subject enrolled on all dose levels.</p>
</div>
<div id="stage-2" class="section level3">
<h3>Stage 2</h3>
<p>If 2 or more doses are considered acceptable after stage 1, the remaining patients are randomized to these open doses until the total sample size N is reached. If only dose 1 is acceptable after stage 1, allocate up to 9 patients (<code>stop.rule = 9</code>)</p>
<p>Function to fit a linear regression for the continuous efficacy outcomes, compute the randomization probabilities per dose and allocate the next subject to an acceptable safe dose that has the highest randomization probability:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">set.seed</span>(<span class="dv">2</span>)
<span class="kw">rand.stg2</span>(dose, dose.tox, p_no, p_yes, K, coh.size, m, v, N, <span class="dt">stop.rule =</span> stop.rule, <span class="dt">cohort =</span> <span class="dv">1</span>, <span class="dt">samedose =</span> T, <span class="dt">nbb =</span> <span class="dv">100</span>) </code></pre></div>
<pre><code>## $Y.final
##  [1]  0  7  4  2 37  6 40 44 32 64 79 72 87 76 98  9 72 65 63 55 46 36 36
## [24] 56  3
## 
## $d.final
##  [1] 1 1 1 2 2 2 3 3 3 4 4 4 5 5 5 2 4 4 4 3 4 3 3 3 2
## 
## $n1
## [1] 15</code></pre>
<p>The complete vectors of dose allocations and efficacy outcomes can be used to compute the operating characteristics of the design in repeated simulations.</p>
<p>To simulate this trial 100 times, we can run the following:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">numsims =<span class="st"> </span><span class="dv">100</span>

<span class="kw">set.seed</span>(<span class="dv">2</span>)
simulations =<span class="st"> </span><span class="kw">sim.trials</span>(<span class="dt">numsims =</span> numsims, dose, dose.tox, <span class="dt">p1 =</span> p_no, <span class="dt">p2 =</span> p_yes, K, coh.size, m, v, N, <span class="dt">stop.rule =</span> stop.rule, <span class="dt">cohort =</span> <span class="dv">1</span>, <span class="dt">samedose =</span> T, <span class="dt">nbb =</span> <span class="dv">100</span>)</code></pre></div>
<pre><code>## 1 
## 2 
## 3 
## 4 
## 5 
## 6 
## 7 
## 8 
## 9 
## 10 
## 11 
## 12 
## 13 
## 14 
## 15 
## 16 
## 17 
## 18 
## 19 
## 20 
## 21 
## 22 
## 23 
## 24 
## 25 
## 26 
## 27 
## 28 
## 29 
## 30 
## 31 
## 32 
## 33 
## 34 
## 35 
## 36 
## 37 
## 38 
## 39 
## 40 
## 41 
## 42 
## 43 
## 44 
## 45 
## 46 
## 47 
## 48 
## 49 
## 50 
## 51 
## 52 
## 53 
## 54 
## 55 
## 56 
## 57 
## 58 
## 59 
## 60 
## 61 
## 62 
## 63 
## 64 
## 65 
## 66 
## 67 
## 68 
## 69 
## 70 
## 71 
## 72 
## 73 
## 74 
## 75 
## 76 
## 77 
## 78 
## 79 
## 80 
## 81 
## 82 
## 83 
## 84 
## 85 
## 86 
## 87 
## 88 
## 89 
## 90 
## 91 
## 92 
## 93 
## 94 
## 95 
## 96 
## 97 
## 98 
## 99 
## 100</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">head</span>(simulations<span class="op">$</span>safe.d)</code></pre></div>
<pre><code>##      [,1] [,2] [,3] [,4] [,5]
## [1,]    1    1    1    1    0
## [2,]    1    1    1    1    0
## [3,]    1    1    1    1    0
## [4,]    1    1    1    0    0
## [5,]    1    1    1    1    0
## [6,]    1    1    1    0    0</code></pre>
<p>$safe.d indicates whether each dose (column) was declared safe in stage 1 (1 = yes, 0 = no) for each trial (row).</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">head</span>(simulations<span class="op">$</span>sim.Y)</code></pre></div>
<pre><code>##      [,1] [,2] [,3] [,4] [,5] [,6] [,7] [,8] [,9] [,10] [,11] [,12] [,13]
## [1,]    0    7    4    2   37    6   40   44   32    64    79    72    87
## [2,]    4    0    4    9    5   38   32   47   37    45    68    68    89
## [3,]    5   10    5   23   10   18   22   45   30    74    58    57    81
## [4,]    2    1    1   56    8   25   26   27   39    65    65    68    36
## [5,]   40   16    1   21   10   21   35   53   36    66    63    68    80
## [6,]    1    4   12   47   15   23   51   25   44    68    89    79    32
##      [,14] [,15] [,16] [,17] [,18] [,19] [,20] [,21] [,22] [,23] [,24]
## [1,]    76    98     9    72    65    63    55    46    36    36    56
## [2,]    89    85    82    73    61    18     5     3     3     3     5
## [3,]    87    64    80    73     0    76    88    60    82    48    44
## [4,]    21    50    21    31    56    18    24    56    21     0    21
## [5,]    80    74    60    42    63    27     3    12     0    84    73
## [6,]    32    49    12    53    15    18    15    46     2    11    10
##      [,25]
## [1,]     3
## [2,]     4
## [3,]    12
## [4,]    24
## [5,]    72
## [6,]     0</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">head</span>(simulations<span class="op">$</span>sim.d)</code></pre></div>
<pre><code>##      [,1] [,2] [,3] [,4] [,5] [,6] [,7] [,8] [,9] [,10] [,11] [,12] [,13]
## [1,]    1    1    1    2    2    2    3    3    3     4     4     4     5
## [2,]    1    1    1    2    2    2    3    3    3     4     4     4     5
## [3,]    1    1    1    2    2    2    3    3    3     4     4     4     5
## [4,]    1    1    1    2    2    2    3    3    3     4     4     4     3
## [5,]    1    1    1    2    2    2    3    3    3     4     4     4     5
## [6,]    1    1    1    2    2    2    3    3    3     4     4     4     3
##      [,14] [,15] [,16] [,17] [,18] [,19] [,20] [,21] [,22] [,23] [,24]
## [1,]     5     5     2     4     4     4     3     4     3     3     3
## [2,]     5     5     5     5     4     2     1     1     1     1     1
## [3,]     5     5     4     5     1     4     5     5     5     3     4
## [4,]     2     2     3     3     3     2     2     3     2     2     2
## [5,]     5     5     5     3     4     3     1     2     1     5     5
## [6,]     3     3     2     3     2     2     3     3     2     2     2
##      [,25]
## [1,]     2
## [2,]     1
## [3,]     2
## [4,]     2
## [5,]     4
## [6,]     1</code></pre>
<p>$sim.Y gives the observed outcomes, where each column corresponds to 1 patient (maximum of N columns), and each row is a simulated trial. Correspondingly, $sim.d gives the dose allocation for each patient (column) in each trial (row).</p>
<p>To see the rate at which we’ve designated each dose as safe in stage 1, we can simply take the column totals of the $safe.d matrix:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">colSums</span>(simulations<span class="op">$</span>safe.d) <span class="op">/</span><span class="st"> </span>numsims</code></pre></div>
<pre><code>## [1] 1.00 0.99 0.87 0.79 0.00</code></pre>
<p>[Need also to show which dose we select as most effective from stage 2 to carry forward into phase II testing.]</p>
</div>
</div>
<div id="scenario-2-non-monotone-dose-response" class="section level2">
<h2>Scenario 2: Non-monotone dose-response</h2>
<p>Here, all parameters are the same as in scenario 1, except for the observed efficacies. Instead, they take on a parabolic nature.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="co"># Vector of true mean efficacies per dose (here mean percent persistence per dose)</span>
m &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">15</span>, <span class="dv">35</span>, <span class="dv">80</span>, <span class="dv">60</span>, <span class="dv">40</span>)   <span class="co"># MUST BE THE SAME LENGTH AS dose.tox                  </span></code></pre></div>
<p>Now we have a non-monotone dose-response curves, as shown below. If we have a cutoff toxicity rate of 0.25, (horizontal dotted line, figure a) and assume a monotone dose-response relationship, then we would choose dose level 4 as we did in the previous scenario (red point). However, note that according to the true efficacies of each dose, the lesser dose number 3 is actually best (green point). Assuming a monotone relationship, we would be incorrectly pushing forward a more toxic and less effective dose level. Again using a likelihood framework, our design should, on average, choose dose level 3 with high accuracy.</p>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<div id="stage-1-1" class="section level3">
<h3>Stage 1</h3>
<p>Stage 1 establishes the safety profiles of the predefined doses. All output can be interpreted in the same way as in scenario 1. However, note that in this case we identify dose level 3 as the last acceptably toxic dose.</p>
<p>Function to generate and tabulate toxicities per dose level.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">set.seed</span>(<span class="dv">1</span>)
<span class="kw">tox.profile</span>(<span class="dt">dose =</span> dose, <span class="dt">dose.tox =</span> dose.tox, <span class="dt">p1 =</span> p_no, <span class="dt">p2 =</span> p_yes, <span class="dt">K =</span> K, <span class="dt">coh.size =</span> coh.size)</code></pre></div>
<pre><code>##      [,1] [,2] [,3] [,4]
## [1,]    1    0    1 1.46
## [2,]    2    0    2 1.46
## [3,]    3    0    3 1.46
## [4,]    4    2    4 0.41</code></pre>
<p>Function to select only the acceptable toxic doses</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">set.seed</span>(<span class="dv">1</span>)
<span class="kw">safe.dose</span>(<span class="dt">dose =</span> dose, <span class="dt">dose.tox =</span> dose.tox, <span class="dt">p1 =</span> p_no, <span class="dt">p2 =</span> p_yes, <span class="dt">K =</span> K, <span class="dt">coh.size =</span> coh.size) </code></pre></div>
<pre><code>## $alloc.safe
##      [,1] [,2]
## [1,]    1    0
## [2,]    2    0
## [3,]    3    0
## 
## $alloc.total
##  [1] 1 1 1 2 2 2 3 3 3 4 4 4
## 
## $n1
## [1] 12</code></pre>
<p>Function to generate efficacy outcomes (here percent persistence) for each dose</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">set.seed</span>(<span class="dv">1</span>)
<span class="kw">eff.stg1</span>(<span class="dt">dose =</span> dose, <span class="dt">dose.tox =</span> dose.tox, <span class="dt">p1 =</span> p_no, <span class="dt">p2 =</span> p_yes, <span class="dt">K =</span> K, <span class="dt">coh.size =</span> coh.size, m, v, <span class="dt">nbb =</span> <span class="dv">100</span>)</code></pre></div>
<pre><code>## $Y.safe
## [1] 11 15  8 30 21 16 84 76 79
## 
## $d.safe
## [1] 1 1 1 2 2 2 3 3 3
## 
## $tox.safe
## [1] 0 0 0
## 
## $n1
## [1] 12
## 
## $Y.alloc
##  [1] 11 15  8 30 21 16 84 76 79 57 47 79
## 
## $d.alloc
##  [1] 1 1 1 2 2 2 3 3 3 4 4 4</code></pre>
</div>
<div id="stage-2-1" class="section level3">
<h3>Stage 2</h3>
<p>If 2 or more doses are considered acceptable after stage 1, the remaining patients are randomized to these open doses until the total sample size N is reached. If only dose 1 is acceptable after stage 1, allocate up to 9 patients (stop.rule=9)</p>
<p>Function to fit a linear regression for the continuous efficacy outcomes, compute the randomization probabilities per dose and allocate the next subject to an acceptable safe dose that has the highest randomization probability.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">set.seed</span>(<span class="dv">1</span>)
<span class="kw">rand.stg2</span>(dose, dose.tox, p_no, p_yes, K, coh.size, m, v, N, <span class="dt">stop.rule =</span> stop.rule, <span class="dt">cohort =</span> <span class="dv">1</span>, <span class="dt">samedose =</span> T, <span class="dt">nbb =</span> <span class="dv">100</span>) </code></pre></div>
<pre><code>## $Y.final
##  [1] 11 15  8 30 21 16 84 76 79 57 47 79 85 84 62 83 75 72 69 80 90 84 88
## [24] 74 34
## 
## $d.final
##  [1] 1 1 1 2 2 2 3 3 3 4 4 4 3 3 3 3 3 3 3 3 3 3 3 3 2
## 
## $n1
## [1] 12</code></pre>
<p>The complete vectors of dose allocations and efficacy outcomes can be used to compute the operating characteristics of the design in repeated simulations.</p>
<p>To simulate this trial 100 times, we can run the following:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">numsims =<span class="st"> </span><span class="dv">100</span>

<span class="kw">set.seed</span>(<span class="dv">1</span>)
simulations =<span class="st"> </span><span class="kw">sim.trials</span>(<span class="dt">numsims =</span> numsims, dose, dose.tox, <span class="dt">p1 =</span> p_no, <span class="dt">p2 =</span> p_yes, K, coh.size, m, v, N, <span class="dt">stop.rule =</span> stop.rule, <span class="dt">cohort =</span> <span class="dv">1</span>, <span class="dt">samedose =</span> T, <span class="dt">nbb =</span> <span class="dv">100</span>)</code></pre></div>
<pre><code>## 1 
## 2 
## 3 
## 4 
## 5 
## 6 
## 7 
## 8 
## 9 
## 10 
## 11 
## 12 
## 13 
## 14 
## 15 
## 16 
## 17 
## 18 
## 19 
## 20 
## 21 
## 22 
## 23 
## 24 
## 25 
## 26 
## 27 
## 28 
## 29 
## 30 
## 31 
## 32 
## 33 
## 34 
## 35 
## 36 
## 37 
## 38 
## 39 
## 40 
## 41 
## 42 
## 43 
## 44 
## 45 
## 46 
## 47 
## 48 
## 49 
## 50 
## 51 
## 52 
## 53 
## 54 
## 55 
## 56 
## 57 
## 58 
## 59 
## 60 
## 61 
## 62 
## 63 
## 64 
## 65 
## 66 
## 67 
## 68 
## 69 
## 70 
## 71 
## 72 
## 73 
## 74 
## 75 
## 76 
## 77 
## 78 
## 79 
## 80 
## 81 
## 82 
## 83 
## 84 
## 85 
## 86 
## 87 
## 88 
## 89 
## 90 
## 91 
## 92 
## 93 
## 94 
## 95 
## 96 
## 97 
## 98 
## 99 
## 100</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">head</span>(simulations<span class="op">$</span>safe.d)</code></pre></div>
<pre><code>##      [,1] [,2] [,3] [,4] [,5]
## [1,]    1    1    1    0    0
## [2,]    1    1    1    1    0
## [3,]    1    1    1    1    0
## [4,]    1    1    1    1    0
## [5,]    1    1    0    0    0
## [6,]    1    1    1    1    0</code></pre>
<p>$safe.d indicates whether each dose (column) was declared safe in stage 1 (1 = yes, 0 = no) for each trial (row).</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">head</span>(simulations<span class="op">$</span>sim.Y)</code></pre></div>
<pre><code>##      [,1] [,2] [,3] [,4] [,5] [,6] [,7] [,8] [,9] [,10] [,11] [,12] [,13]
## [1,]   11   15    8   30   21   16   84   76   79    57    47    79    85
## [2,]   16   15    2   28   52   32   78   74   62    63    46    39    52
## [3,]   10   23   11   37   21   30   88   82   79    49    78    62    36
## [4,]   13   23   18   26   30   36   73   86   81    49    46    71    42
## [5,]   14   16    1   26   22   23   78   92   87    35    28    22    33
## [6,]    5   28    7   38   45   36   72   67   74    54    67    53    28
##      [,14] [,15] [,16] [,17] [,18] [,19] [,20] [,21] [,22] [,23] [,24]
## [1,]    84    62    83    75    72    69    80    90    84    88    74
## [2,]    34    42    37     7     9    10    15    10     8    NA    NA
## [3,]    55    36    83    74    18    72    42    45    93    38    77
## [4,]    50    48    64    71    33    36    37    72    42    67    87
## [5,]    25     4    15    12    31    21    42    16    11    25     4
## [6,]    38    37    35    66    68    75    83    85    30    30    73
##      [,25]
## [1,]    34
## [2,]    NA
## [3,]     5
## [4,]    93
## [5,]    27
## [6,]    34</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">head</span>(simulations<span class="op">$</span>sim.d)</code></pre></div>
<pre><code>##      [,1] [,2] [,3] [,4] [,5] [,6] [,7] [,8] [,9] [,10] [,11] [,12] [,13]
## [1,]    1    1    1    2    2    2    3    3    3     4     4     4     3
## [2,]    1    1    1    2    2    2    3    3    3     4     4     4     5
## [3,]    1    1    1    2    2    2    3    3    3     4     4     4     5
## [4,]    1    1    1    2    2    2    3    3    3     4     4     4     5
## [5,]    1    1    1    2    2    2    3    3    3     2     2     1     1
## [6,]    1    1    1    2    2    2    3    3    3     4     4     4     5
##      [,14] [,15] [,16] [,17] [,18] [,19] [,20] [,21] [,22] [,23] [,24]
## [1,]     3     3     3     3     3     3     3     3     3     3     3
## [2,]     5     5     2     1     1     1     1     1     1    NA    NA
## [3,]     5     5     3     3     2     3     2     2     3     2     3
## [4,]     5     5     2     3     5     2     2     3     2     3     3
## [5,]     1     1     1     1     2     1     2     1     1     2     1
## [6,]     5     5     2     4     3     3     3     3     2     2     3
##      [,25]
## [1,]     2
## [2,]    NA
## [3,]     1
## [4,]     3
## [5,]     2
## [6,]     2</code></pre>
<p>$sim.Y gives the observed outcomes, where each column corresponds to 1 patient (maximum of N columns), and each row is a simulated trial. Correspondingly, $sim.d gives the dose allocation for each patient (column) in each trial (row).</p>
<p>To see the rate at which we’ve designated each dose as safe in stage 1, we can simply take the column totals of the $safe.d matrix:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">colSums</span>(simulations<span class="op">$</span>safe.d) <span class="op">/</span><span class="st"> </span>numsims</code></pre></div>
<pre><code>## [1] 0.98 0.97 0.94 0.82 0.00</code></pre>
<p>[Need also to show which dose we select as most effective from stage 2 to carry forward into phase II testing.]</p>
</div>
</div>



<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
